REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 152 filers reported holding REATA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 3.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $10,196 | -59.2% | 100 | -63.6% | 0.01% | -57.9% |
Q1 2023 | $25,003 | +139.3% | 275 | 0.0% | 0.02% | +171.4% |
Q4 2022 | $10,447 | +49.2% | 275 | 0.0% | 0.01% | +40.0% |
Q3 2022 | $7,000 | -12.5% | 275 | 0.0% | 0.01% | 0.0% |
Q2 2022 | $8,000 | +33.3% | 275 | 0.0% | 0.01% | +25.0% |
Q1 2022 | $6,000 | – | 275 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CPMG Inc | 2,896,901 | $76,391,000 | 14.09% |
Opaleye Management Inc. | 330,000 | $8,702,000 | 1.85% |
Highlander Partners, L.P. | 27,600 | $728,000 | 0.89% |
Ikarian Capital, LLC | 200,000 | $5,274,000 | 0.79% |
Integral Health Asset Management, LLC | 103,000 | $2,716,000 | 0.75% |
KRS Capital Management, LLC | 32,841 | $866,000 | 0.74% |
Ghost Tree Capital, LLC | 55,000 | $1,450,000 | 0.52% |
MADDEN SECURITIES Corp | 39,312 | $1,037,000 | 0.49% |
LBJ Family Wealth Advisors, Ltd. | 30,359 | $801,000 | 0.47% |
Ikarian Capital, LLC | 100,000 | $2,637,000 | 0.39% |